Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. Amazon Location Service.

Clinical trial site

Rush University Medical Center

Rush University Medical Center in Chicago, Illinois, United States is listed as a site for 1,464 registered clinical trials, 310 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 1,464
Ongoing 310

This page covers the site record Rush University Medical Center in Chicago, Illinois, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, Rush University Medical Center, also sponsors trials.

Get the Rush University Medical Center report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 1,464 trials counted.

  • Phase 1 47 trials
  • Phase 1/2 49 trials
  • Phase 2 316 trials
  • Phase 2/3 33 trials
  • Phase 3 375 trials
  • Phase 4 79 trials
  • Not applicable 362 trials
  • Observational 192 trials
  • Expanded access 11 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 312 trials
  • Completed 871 trials
  • Terminated 228 trials
  • Other 53 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Expanded access)

Top of scale: 104

1992: 1 trials (Observational 1) 1993: 1 trials (Phase 3 1) 1997: 3 trials (Observational 1, Phase 3 2) 1998: 1 trials (Phase 3 1) 1999: 5 trials (Observational 1, Phase 3 3, Phase 2 1) 2000: 7 trials (Observational 2, Phase 3 4, Phase 2 1) 2001: 3 trials (Observational 1, Phase 3 2) 2002: 6 trials (Observational 1, Not applicable 1, Phase 4 1, Phase 3 1, Phase 2 2) 2003: 10 trials (Phase 4 1, Phase 3 6, Phase 2 3) 2004: 25 trials (Observational 3, Not applicable 1, Phase 3 10, Phase 2 9, Phase 1/2 1, Phase 1 1) 2005: 33 trials (Observational 5, Not applicable 4, Phase 4 1, Phase 3 13, Phase 2/3 1, Phase 2 7, Phase 1 2) 2006: 48 trials (Other 1, Observational 6, Not applicable 1, Phase 4 2, Phase 3 17, Phase 2 15, Phase 1/2 4, Phase 1 2) 2007: 46 trials (Observational 4, Not applicable 6, Phase 4 1, Phase 3 11, Phase 2/3 1, Phase 2 21, Phase 1 2) 2008: 56 trials (Observational 3, Not applicable 6, Phase 4 4, Phase 3 15, Phase 2 24, Phase 1/2 2, Phase 1 2) 2009: 59 trials (Observational 4, Not applicable 8, Phase 4 6, Phase 3 19, Phase 2 19, Phase 1/2 3) 2010: 50 trials (Observational 8, Not applicable 2, Phase 4 6, Phase 3 15, Phase 2/3 1, Phase 2 15, Phase 1/2 1, Phase 1 2) 2011: 61 trials (Observational 5, Not applicable 15, Phase 4 4, Phase 3 14, Phase 2 19, Phase 1/2 3, Phase 1 1) 2012: 52 trials (Observational 9, Not applicable 10, Phase 4 2, Phase 3 13, Phase 2/3 3, Phase 2 11, Phase 1/2 4) 2013: 58 trials (Observational 7, Not applicable 13, Phase 4 3, Phase 3 18, Phase 2/3 1, Phase 2 10, Phase 1/2 5, Phase 1 1) 2014: 64 trials (Observational 9, Not applicable 16, Phase 4 1, Phase 3 10, Phase 2/3 6, Phase 2 16, Phase 1/2 2, Phase 1 4) 2015: 83 trials (Observational 15, Not applicable 19, Phase 3 18, Phase 2/3 4, Phase 2 17, Phase 1/2 5, Phase 1 5) 2016: 79 trials (Observational 10, Not applicable 20, Phase 4 9, Phase 3 18, Phase 2/3 3, Phase 2 12, Phase 1/2 2, Phase 1 5) 2017: 95 trials (Observational 8, Not applicable 19, Phase 4 10, Phase 3 30, Phase 2/3 1, Phase 2 23, Phase 1/2 3, Phase 1 1) 2018: 104 trials (Observational 28, Not applicable 29, Phase 4 2, Phase 3 28, Phase 2/3 3, Phase 2 11, Phase 1/2 1, Phase 1 2) 2019: 83 trials (Observational 10, Not applicable 30, Phase 4 3, Phase 3 15, Phase 2/3 3, Phase 2 13, Phase 1/2 3, Phase 1 6) 2020: 88 trials (Observational 18, Not applicable 31, Phase 4 6, Phase 3 18, Phase 2 11, Phase 1/2 1, Phase 1 3) 2021: 71 trials (Observational 4, Not applicable 23, Phase 4 3, Phase 3 22, Phase 2/3 3, Phase 2 14, Phase 1/2 1, Phase 1 1) 2022: 74 trials (Observational 9, Not applicable 31, Phase 4 2, Phase 3 14, Phase 2/3 2, Phase 2 11, Phase 1/2 2, Phase 1 3) 2023: 54 trials (Observational 8, Not applicable 19, Phase 4 2, Phase 3 15, Phase 2 9, Phase 1/2 1) 2024: 36 trials (Observational 6, Not applicable 20, Phase 4 1, Phase 3 2, Phase 2 5, Phase 1/2 1, Phase 1 1) 2025: 58 trials (Observational 5, Not applicable 24, Phase 4 5, Phase 3 11, Phase 2/3 1, Phase 2 8, Phase 1/2 3, Phase 1 1)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 38
2025 58
2024 36
2023 54
2022 74
2021 71
2020 88
2019 83
2018 104
2017 95

Showing 10 of 32 years.

Start your 14-day trial Email me all 32 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 1,464 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 408 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 570 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF